AI made execution free. Knowing first is the whole game now.
The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.
Trusted by
Acquiring Company
Kimberly-Clark
Acquired Company
Kenvue
Description
Kimberly-Clark has proposed remedies to the European Commission as part of its planned acquisition of Kenvue for $49 billion. The regulator has set a provisional deadline of October 13 for a decision on the deal. This acquisition aims to enhance Kimberly-Clark's portfolio in the personal-care market.
Fundz sees it the moment Kimberly-Clark makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired Kenvue?
Kenvue was acquired by Kimberly-Clark, based in Irving. The deal was reported on September 23, 2026. Kimberly-Clark Corp is an Irving-based consumer products giant with a portfolio of well-known brands such as Huggies, Kleenex, Scott, Kotex, and others. Kimberly-Clark is publicly traded (KMB) and operates in Manufacturing.
When did Kimberly-Clark acquire Kenvue?
Kimberly-Clark's acquisition of Kenvue was reported on September 23, 2026. Kimberly-Clark has proposed remedies to the European Commission as part of its planned acquisition of Kenvue for $49 billion. The regulator has set a provisional deadline of October 13 for a decision on the deal. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Kenvue do?
Kenvue is a consumer health spinoff of Johnson & Johnson, specializing in global corporate affairs and a portfolio of brands including Band-Aid, Listerine, Tylenol, and Neutrogena. It is publicly traded (KVUE), operating in Health Care, and is based in Summit.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
5 screens from a live account. No signup.